Pay in installments of $6.82 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 22 - Jul 27
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
glp 1 weight loss houma Semaglutide Weight Loss Injections & Clinics Near You What Gastrointestinal Side Effects Qualify for Ozempic Lawsuits? Ozempic Before and After: Real Weight Loss Stories Retatrutide (GLP 1 GIP Glucagon) peptides Teladoc partnering with Eli Lilly on self pay GLP 1 access Healthcare Finance News Lebrikizumab Wins FDA Approval for Eczema MedPage Today
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.6 ★★★★★
Based on 27 reviews
Sort
Product Reviews
★★★★★ 5
Hurrah for Jon Bowlby
Format: Paperback
Early work by someone who offered a contrast to Freud and who led the way to understanding the needs of young children. A cornerstone of most of the work of therapists today.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 5, 2015
★★★★★ 5
One of Bowlby's 3 seminal books on topic
Format: Paperback
Separation: anxiety and Anger. If we want to understand the anger of the teens and twenty - somethings and adults, read this book. without attachment it is not possible to formulate a supportive society.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 1, 2012
★★★★★ 5
Necessary read
Format: Paperback
Great for understanding the damage done to children and adults who were abandoned,separated,etc and for understanding the importance of a mother and fathers love and presence.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 24, 2014
★★★★★ 5
Good to use every night...I do.
If you suffer from dry mouth during the night, these are the perfect solution. I had tried rinses - they don't last. Sprays - they don't last. lozenges - don't last. Other tablets, only last a few hours. I can get about 8 hours relief with these. Contrary to other reviews, you do not suck on them like a lozenge...they won't last at all if you do it that way. Read the directions. They "adhere" to your back molars...don't drink or eat after putting them in...as both will either dislodge or reduce the effectiveness. However, when I don't use these, my mouth is miserable and so dry. These provide enough moisture throughout the night. The flavors aren't too bad. I've used the mint (not may favorite because I'm not a fan of mint flavor), orange and berry. I wish they had other flavors (cinnamon, licorice), but till then, I'll use these probably forever.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 2, 2026
★★★★★ 5
Really helpful for dry mouth.
Scent Name: Berry, Size: 100 Count
These really work. I wear a CPAP and my mouth was so dry I was waking up with my tongue stuck to the roof of my mouth. They stick well so no worry of swallowing it during the night. I like the berry flavor.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 25, 2026
recommand products
Visceral Fat Reduction & Recovery with advanced testing in NYC
28.43
has tirzepatide been fda approved Breaking News: FDA Approves Tirzepatide For Treating Obesity
28.07
GROUNDBREAKING UPDATE! FDA has approved TIRZEPATIDE, a pioneering obesity treatment activating GIP & GLP-1 receptors, for weight loss! Previously, Tirzepatide has been FDA approved for type 2 diabetes as Mounjaro, and although
25.75
fda tirzepatide approval Weight-Loss Drugs: What's in Them and How They Work
24.02
tirzepatide fda approval date The Landscape Of GLP-1 Receptor Agonists In Diabetes And Obesity Treatment
21.64